Sage Journals: Discover world-class research

Abstract

Aims

To investigate the effect of weight loss induced by bariatric surgery and intensive lifestyle intervention on levels of circulating high-sensitivity cardiac troponin I.

Methods and Results

We measured high-sensitivity cardiac troponin I concentrations pre- and 12 months post-intervention in 136 subjects with morbid obesity participating in a controlled clinical trial comparing the effect of intensive lifestyle intervention vs. Roux-en-Y gastric bypass. At baseline median (interquartile range) high-sensitivity cardiac troponin I levels were 2.40 (1.28–3.95) ng/L in the bariatric surgery group and 2.35 (1.38–4.40) ng/L in the intensive lifestyle intervention group (p = 0.736). The high-sensitivity cardiac troponin I concentration in a normal-weight control group was 0.90 (0.60–2.13) ng/L. During 12 months of follow-up, high-sensitivity cardiac troponin I decreased significantly more in the bariatric surgery group than in the intensive lifestyle intervention group (0.80 (0–1.80) vs. 0.15 (−0.50 to 1.00) ng/L; p = 0.002). In a multivariate logistic regression model, surgery emerged as a predictor of reduction in high-sensitivity cardiac troponin I levels (odds ratio 2.32; 95% confidence intervals 1.03–5.22; p = 0.041) independent of age, gender and other possible confounding baseline variables. In subsequent multivariate analyses, reductions in body weight and triglycerides emerged as possible mediators of reduction in circulating levels of high-sensitivity cardiac troponin I.

Conclusion

In patients with morbid obesity, bariatric surgery was associated with a significantly greater reduction in high-sensitivity cardiac troponin I, an index of subclinical myocardial injury, than intensive lifestyle intervention. The reduction appeared to be mediated by reductions in body weight and serum triglycerides. This suggests that weight loss following bariatric surgery may reduce cardiometabolic stress and subsequent risk of heart failure.

Keywords

Obesity bariatric surgery lifestyle intervention weight loss troponin

Get full access to this article

View all access options for this article.

References

WHO. Fact sheet No 311: Obesity and overweight, Geneva: WHO, 2014.

WHO. Obesity: preventing and managing the global epidemic. Report of a WHO consultation. World Health Organ Tech Rep Ser 2000; 894: i–xii. 1–253.

James

Rigby

Leach

. The obesity epidemic, metabolic syndrome and future prevention strategies. Eur J Cardiovasc Prev Rehabil 2004; 11: 3–8.

Franz

VanWormer

Crain

. Weight-loss outcomes: a systematic review and meta-analysis of weight-loss clinical trials with a minimum 1-year follow-up. J Am Diet Assoc 2007; 107: 1755–1767.

Buchwald

Oien

. Metabolic/bariatric surgery worldwide 2011. Obes Surg 2013; 23: 427–436.

Bella

Devereux

Roman

. Relations of left ventricular mass to fat-free and adipose body mass: the strong heart study. The Strong Heart Study Investigators. Circulation 1998; 98: 2538–2544.

Szczepaniak

Victor

Orci

. Forgotten but not gone: the rediscovery of fatty heart, the most common unrecognized disease in America. Circ Res 2007; 101: 759–767.

Ikramuddin

Korner

Lee

. Roux-en-Y gastric bypass vs intensive medical management for the control of type 2 diabetes, hypertension, and hyperlipidemia: the Diabetes Surgery Study randomized clinical trial. JAMA 2013; 309: 2240–2249.

Hofso

Nordstrand

Johnson

. Obesity-related cardiovascular risk factors after weight loss: a clinical trial comparing gastric bypass surgery and intensive lifestyle intervention. Eur J Endocrinol 2010; 163: 735–745.

10.

Owan

Avelar

Morley

. Favorable changes in cardiac geometry and function following gastric bypass surgery: 2-year follow-up in the Utah obesity study. J Am Coll Cardiol 2011; 57: 732–739.

11.

Graziani

Leone

Cialdella

. Effects of bariatric surgery on cardiac remodeling: clinical and pathophysiologic implications. Int J Cardiol 2013; 168: 4277–4279.

12.

Algahim

Lux

Leichman

. Progressive regression of left ventricular hypertrophy two years after bariatric surgery. Am J Med 2010; 123: 549–555.

13.

Shah RV, Murthy VL, Abbasi SA, et al. Weight loss and progressive left ventricular remodelling: The Multi-Ethnic Study of Atherosclerosis (MESA). Eur J Prev Cardiol 2015; 22: 1408–1418.

14.

de Lemos

Drazner

Omland

. Association of troponin T detected with a highly sensitive assay and cardiac structure and mortality risk in the general population. JAMA 2010; 304: 2503–2512.

15.

deFilippi

de Lemos

Christenson

. Association of serial measures of cardiac troponin T using a sensitive assay with incident heart failure and cardiovascular mortality in older adults. JAMA 2010; 304: 2494–2502.

16.

Saunders

Nambi

de Lemos

. Cardiac troponin T measured by a highly sensitive assay predicts coronary heart disease, heart failure, and mortality in the Atherosclerosis Risk in Communities Study. Circulation 2011; 123: 1367–1376.

17.

Eggers

Venge

Lindahl

. Cardiac troponin I levels measured with a high-sensitive assay increase over time and are strong predictors of mortality in an elderly population. J Am Coll Cardiol 2013; 61: 1906–1913.

18.

Zeller

Tunstall-Pedoe

Saarela

. High population prevalence of cardiac troponin I measured by a high-sensitivity assay and cardiovascular risk estimation: the MORGAM Biomarker Project Scottish Cohort. Eur Heart J 2014; 35: 271–281.

19.

Eggers

Al-Shakarchi

Berglund

. High-sensitive cardiac troponin T and its relations to cardiovascular risk factors, morbidity, and mortality in elderly men. Am Heart J 2013; 166: 541–548.

20.

Ndumele

Coresh

Lazo

. Obesity, subclinical myocardial injury, and incident heart failure. JACC Heart Fail 2014; 2: 600–607.

21.

Omland

de Lemos

Sabatine

. A sensitive cardiac troponin T assay in stable coronary artery disease. N Engl J Med 2009; 361: 2538–2547.

22.

Omland

Pfeffer

Solomon

. Prognostic value of cardiac troponin I measured with a highly sensitive assay in patients with stable coronary artery disease. J Am Coll Cardiol 2013; 61: 1240–1249.

23.

White

Tonkin

Simes

. Association of contemporary sensitive troponin I levels at baseline and change at 1 year with long-term coronary events following myocardial infarction or unstable angina: results from the LIPID Study (Long-Term Intervention With Pravastatin in Ischaemic Disease). J Am Coll Cardiol 2014; 63: 345–354.

24.

Hofso

Ueland

Hager

. Inflammatory mediators in morbidly obese subjects: associations with glucose abnormalities and changes after oral glucose. Eur J Endocrinol 2009; 161: 451–458.

25.

Rosjo

Kravdal

Hoiseth

. Troponin I measured by a high-sensitivity assay in patients with suspected reversible myocardial ischemia: data from the Akershus Cardiac Examination (ACE) 1 study. Clin Chem 2012; 58: 1565–1573.

26.

Omland

de Lemos

Holmen

. Impact of sex on the prognostic value of high-sensitivity cardiac troponin i in the general population: The HUNT study. Clin Chem 2015; 61: 646–656.

27.

Hubert

Feinleib

Mcnamara

. Obesity as an independent risk factor for cardiovascular-disease – a 26-year follow-up of participants in the Framingham Heart-Study. Circulation 1983; 67: 968–977.

28.

Ogden

Bazzano

. Risk factors for congestive heart failure in US men and women: NHANES I epidemiologic follow-up study. Arch Intern Med 2001; 161: 996–1002.

29.

McGavock

Lingvay

Zib

. Cardiac steatosis in diabetes mellitus: a 1H-magnetic resonance spectroscopy study. Circulation 2007; 116: 1170–1175.

30.

Sjostrom

. Review of the key results from the Swedish Obese Subjects (SOS) trial – a prospective controlled intervention study of bariatric surgery. J Intern Med 2013; 273: 219–234.

31.

Rider

Francis

Ali

. Beneficial cardiovascular effects of bariatric surgical and dietary weight loss in obesity. J Am Coll Cardiol 2009; 54: 718–726.

32.

deFilippi

de Lemos

Tkaczuk

. Physical activity, change in biomarkers of myocardial stress and injury, and subsequent heart failure risk in older adults. J Am Coll Cardiol 2012; 60: 2539–2547.

33.

Lauer

Anderson

Kannel

. The impact of obesity on left ventricular mass and geometry. The Framingham Heart Study. JAMA 1991; 266: 231–236.

34.

Murdolo G, Angeli F, Reboldi G, et al. Left ventricular hypertrophy and obesity: Only a matter of fat? High Blood Press Cardiovasc Prev 2015; 22: 29–41.

35.

Grapsa

Tan

Paschou

. The effect of bariatric surgery on echocardiographic indices: a review of the literature. Eur J Clin Invest 2013; 43: 1224–1230.

36.

Graziani

Cialdella

Liuzzo

. Cardiovascular risk in obesity: different activation of inflammation and immune system between obese and morbidly obese subjects. Eur J Intern Med 2011; 22: 418–423.

37.

Sjostrom

Peltonen

Jacobson

. Bariatric surgery and long-term cardiovascular events. JAMA 2012; 307: 56–65.

38.

Apple

Ler

Murakami

. Determination of 19 cardiac troponin I and T assay 99th percentile values from a common presumably healthy population. Clin Chem 2012; 58: 1574–1581.

39.

Neeland

Drazner

Berry

. Biomarkers of chronic cardiac injury and hemodynamic stress identify a malignant phenotype of left ventricular hypertrophy in the general population. J Am Coll Cardiol 2013; 61: 187–195.

40.

Zeller

Ojeda

Brunner

. High-sensitivity cardiac troponin I in the general population –defining reference populations for the determination of the 99th percentile in the Gutenberg Health Study. Clin Chem Lab Med 2015; 53: 699–706.

Supplementary Material

Please find the following supplemental material available below.

For Open Access articles published under a Creative Commons License, all supplemental material carries the same license as the article it is associated with.

For non-Open Access articles published, all supplemental material carries a non-exclusive license, and permission requests for re-use of supplemental material or any part of supplemental material shall be sent directly to the copyright owner as specified in the copyright notice associated with the article.

0.00 MB

0.49 MB

Effect of weight loss on subclinical myocardial injury: A clinical trial comparing gastric bypass surgery and intensive lifestyle intervention

Abstract

Aims

Methods and Results

Conclusion

Keywords

Get full access to this article

References

Supplementary Material